Xin Hu

Xin Hu

National Center for Advancing Translational Sciences, National Institutes of Health

Affiliated withNational Institutes of HealthGerman Center for Neurodegenerative Diseases (DZNE)

Research Area

Biography

Xinyan Huang is work at Dr. Antony Rodriguez lab as a postdoc from 2019.6 to 2021.5.

JoVE Journal Publications

ArticleTotal : 2
Year
Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
Publication title

Cited by 5

2019
2024

Other Publications

Article
Year
LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 19497860

2009
2010
2011
2012
Discovery of a novel noniminosugar acid α glucosidase chaperone series.

Journal of medicinal chemistry| PubMed ID: 22834902

2012
2013
2013
2013
2013
2013
2013
2014
2014
2014
2014
2014
2014
2014
2015
2015
2015
2015
2015
2015
2016
2016
CERAPP: Collaborative Estrogen Receptor Activity Prediction Project.

Environmental health perspectives| PubMed ID: 26908244

2016
Targeting Estrogen Receptor Signaling with Fulvestrant Enhances Immune and Chemotherapy-Mediated Cytotoxicity of Human Lung Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 27267852

2016
2016
2016
2016
Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1.

British journal of pharmacology| PubMed ID: 27771940

2017
2017
2017
2018
2017
2018
In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 29632194

2018
2018
2018
2018
2018
Discovery and lead identification of quinazoline-based BRD4 inhibitors.

Bioorganic & medicinal chemistry letters| PubMed ID: 30268702

2018
2018
2019
2019
Discovery of novel inhibitors of human galactokinase by virtual screening.

Journal of computer-aided molecular design| PubMed ID: 30806949

2019
2019
Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 31419161

2019
2022
2023